In 2005, it was demonstrated that MPNs are connected by an acquired somatic mutation of the JAK2 gene, JAK2 V617F [2], which is found in approximately 95% of patients with PV and in 50% of patients with ET or PMF. The gene discussed is JAK2; the disease is essential thrombocythemia.